7-bromo-N-tert-butyl-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-5-amine;cis-(1R,3S)-3-aminocyclopentan-1-ol;bis(cis-(1R,3S)-3-[[5-amino-2-(1H-pyrazol-5-yl)thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol);cis-(1R,3S)-3-[[5-(tert-butylamino)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol;hydrochloride
C78H102BrClN20O6S4 — CID 163505435
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-bromo-N-tert-butyl-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-5-amine;cis-(1R,3S)-3-aminocyclopentan-1-ol;bis(cis-(1R,3S)-3-[[5-amino-2-(1H-pyrazol-5-yl)thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol);cis-(1R,3S)-3-[[5-(tert-butylamino)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol;hydrochloride
7-bromo-N-tert-butyl-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-5-amine;cis-(1R,3S)-3-aminocyclopentan-1-ol;bis(cis-(1R,3S)-3-[[5-amino-2-(1H-pyrazol-5-yl)thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol);cis-(1R,3S)-3-[[5-(tert-butylamino)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol;hydrochloride (PubChem CID 163505435) has the molecular formula C78H102BrClN20O6S4 and a molecular weight of 1659.43 g/mol. Its IUPAC name is 7-bromo-N-tert-butyl-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-5-amine;cis-(1R,3S)-3-aminocyclopentan-1-ol;bis(cis-(1R,3S)-3-[[5-amino-2-(1H-pyrazol-5-yl)thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol);cis-(1R,3S)-3-[[5-(tert-butylamino)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol;hydrochloride.
Molecular Properties
| Compound Name | 7-bromo-N-tert-butyl-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-5-amine;cis-(1R,3S)-3-aminocyclopentan-1-ol;bis(cis-(1R,3S)-3-[[5-amino-2-(1H-pyrazol-5-yl)thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol);cis-(1R,3S)-3-[[5-(tert-butylamino)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol;hydrochloride |
|---|---|
| PubChem CID | 163505435 |
| Molecular Formula | C78H102BrClN20O6S4 |
| Molecular Weight | 1659.43 g/mol |
| Exact Mass | 1656.60 |
| IUPAC Name | 7-bromo-N-tert-butyl-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-5-amine;cis-(1R,3S)-3-aminocyclopentan-1-ol;bis(cis-(1R,3S)-3-[[5-amino-2-(1H-pyrazol-5-yl)thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol);cis-(1R,3S)-3-[[5-(tert-butylamino)-2-[2-(oxan-2-yl)pyrazol-3-yl]thieno[3,2-b]pyridin-7-yl]amino]cyclopentan-1-ol;hydrochloride |
| SMILES | CC(C)(C)Nc1cc(Br)c2sc(-c3ccnn3C3CCCCO3)cc2n1.CC(C)(C)Nc1cc(N[C@H]2CC[C@@H](O)C2)c2sc(-c3ccnn3C3CCCCO3)cc2n1.Cl.N[C@H]1CC[C@@H](O)C1.Nc1cc(N[C@H]2CC[C@@H](O)C2)c2sc(-c3ccn[nH]3)cc2n1.Nc1cc(N[C@H]2CC[C@@H](O)C2)c2sc(-c3ccn[nH]3)cc2n1 |
| InChI | InChI=1S/C24H33N5O2S.C19H23BrN4OS.2C15H17N5OS.C5H11NO.ClH/c1-24(2,3)28-21-14-18(26-15-7-8-16(30)12-15)23-17(27-21)13-20(32-23)19-9-10-25-29(19)22-6-4-5-11-31-22;1-19(2,3)23-16-10-12(20)18-13(22-16)11-15(26-18)14-7-8-21-24(14)17-6-4-5-9-25-17;2*16-14-7-12(18-8-1-2-9(21)5-8)15-11(19-14)6-13(22-15)10-3-4-17-20-10;6-4-1-2-5(7)3-4;/h9-10,13-16,22,30H,4-8,11-12H2,1-3H3,(H2,26,27,28);7-8,10-11,17H,4-6,9H2,1-3H3,(H,22,23);2*3-4,6-9,21H,1-2,5H2,(H,17,20)(H3,16,18,19);4-5,7H,1-3,6H2;1H/t15-,16+,22?;;2*8-,9+;4-,5+;/m0.000./s1 |
| InChIKey | OOIUHBOCWXMDPI-RWQGVZQZSA-N |
| XLogP | 16.69 |
| TPSA | 382.15 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 110 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1659.43 |
| LogP ≤ 5 | 16.69 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 28 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163505435 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.